Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allisartan isoproxil for endothelial function and vascular injury in mild essential hypertension
ChiCTR2000032332Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of allisartan isoproxil in essential hypertension (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: blood pressure. Started Dec 2018; status: completed.
02
Drugs
allisartan isoproxil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2000032332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032332.